Difference between losartan and valsartan
Pro Research Analysisby 
Searched over 200M research papers
Consensus Meter
Differences Between Losartan and Valsartan in Hypertension Treatment
Introduction to Losartan and Valsartan
Losartan and valsartan are both angiotensin II receptor blockers (ARBs) used to treat hypertension. While they share a common mechanism of action, there are notable differences in their efficacy, tolerability, and pharmacological profiles.
Efficacy in Blood Pressure Reduction
Comparative Efficacy
Several studies have compared the antihypertensive efficacy of losartan and valsartan. Both drugs have been shown to significantly reduce blood pressure in patients with mild to moderate hypertension. In a 12-week trial, losartan (50 mg) and valsartan (80 mg) were found to be equally effective in lowering sitting diastolic blood pressure (SiDBP) with a mean reduction of 9.9 mm Hg for losartan and 10.1 mm Hg for valsartan. Another study confirmed similar findings, showing that both drugs significantly reduced blood pressure compared to placebo, with valsartan having a slightly higher responder rate (62%) compared to losartan (55%) at the 8-week endpoint.
Ambulatory Blood Pressure Monitoring
Ambulatory blood pressure monitoring (ABPM) has also been used to compare these ARBs. One study found that both losartan and valsartan significantly reduced 24-hour blood pressure, but losartan provided a more consistent blood pressure-lowering effect throughout the day, as indicated by a higher smoothness index. Another study supported these findings, showing that valsartan had better antihypertensive efficacy in 24-hour, daytime, and nighttime ABPM values compared to losartan.
Tolerability and Side Effects
General Tolerability
Both losartan and valsartan are generally well-tolerated. Common adverse events include headache and dizziness, with no significant differences in the incidence of these events between the two drugs. However, losartan has been associated with a significant decrease in serum uric acid levels, which was not observed with valsartan .
Specific Side Effects
Valsartan has been noted to have a lower incidence of dry cough compared to ACE inhibitors, making it a suitable alternative for patients who experience this side effect with ACE inhibitors. Additionally, valsartan has shown a greater influence on AT2-receptor-mediated responses, as indicated by higher increases in renal interstitial fluid cGMP levels compared to losartan.
Pharmacological Differences
Binding Sites and Molecular Interactions
Molecular modeling studies have shown that valsartan and losartan interact differently with the angiotensin II type 1 receptor (AT1). Valsartan interacts with a higher number of binding sites compared to losartan, which may contribute to its slightly higher efficacy in some studies.
Cost-Effectiveness
A cost-effectiveness analysis indicated that valsartan might be more cost-effective compared to switching to generic losartan, especially considering the potential for better blood pressure control and fewer cardiovascular events.
Conclusion
While losartan and valsartan are both effective ARBs for treating hypertension, they exhibit some differences in efficacy, tolerability, and pharmacological properties. Valsartan may offer slightly better blood pressure control and has a lower incidence of certain side effects, while losartan is associated with a beneficial reduction in serum uric acid levels. The choice between these two medications should be individualized based on patient-specific factors and clinical response.
Sources and full results
Most relevant research papers on this topic